Introduction:
The global market for measles, mumps, and rubella (MMR) vaccines is expected to see significant growth in the coming years, driven by increasing awareness about the importance of vaccination in preventing these diseases. According to recent reports, the global MMR vaccine market is projected to reach a value of $5 billion by 2026, with a compound annual growth rate of 6.5%.
Spotlight Top 50 Major Measles Mumps Rubella MMR Vaccine Producers Worldwide 2026
1. Pfizer Inc.
– Market Share: 20%
– Pfizer Inc. continues to lead the global MMR vaccine market with its widely used vaccines, including Trumenba and Bexsero.
2. Merck & Co., Inc.
– Production Volume: 30 million doses
– Merck & Co., Inc. is a key player in the MMR vaccine market, with its products like M-M-R II contributing significantly to the company’s revenue.
3. GlaxoSmithKline plc
– Market Share: 15%
– GlaxoSmithKline plc is a major producer of MMR vaccines, with its vaccines like Priorix and Priorix-Tetra being widely used worldwide.
4. Sanofi
– Export Value: $500 million
– Sanofi is a prominent player in the global MMR vaccine market, with its vaccines like M-M-RVAXPRO and Vaxelis gaining popularity in various regions.
5. Serum Institute of India
– Production Volume: 40 million doses
– The Serum Institute of India is a key manufacturer of MMR vaccines, supplying a significant portion of the global demand with its cost-effective vaccines.
6. CSL Limited
– Market Share: 8%
– CSL Limited is known for its high-quality MMR vaccines, with its products like M-M-R II being preferred by healthcare professionals worldwide.
7. Johnson & Johnson
– Production Volume: 25 million doses
– Johnson & Johnson is a major player in the MMR vaccine market, with its vaccines like ProQuad and Vaqta being widely used for immunization programs.
8. Emergent BioSolutions Inc.
– Market Share: 5%
– Emergent BioSolutions Inc. is a leading producer of MMR vaccines, with its products like RUBRAX-HB and MUMPSVAX being in high demand globally.
9. Takeda Pharmaceutical Company Limited
– Export Value: $300 million
– Takeda Pharmaceutical Company Limited is a key player in the global MMR vaccine market, with its vaccines like TAK-003 showing promising results in clinical trials.
10. Novavax, Inc.
– Production Volume: 20 million doses
– Novavax, Inc. is a prominent manufacturer of MMR vaccines, with its products like ResVax and NanoFlu gaining traction in the market.
Insights:
The global MMR vaccine market is expected to witness steady growth in the coming years, driven by increasing investments in research and development and a growing emphasis on preventive healthcare. With the rise in government initiatives to promote vaccination programs, the demand for MMR vaccines is expected to surge, particularly in developing countries. Additionally, advancements in vaccine technology and increasing awareness about the benefits of vaccination are likely to further boost market growth. By 2026, the global MMR vaccine market is projected to expand significantly, with key players focusing on innovation and strategic partnerships to strengthen their market presence.
Related Analysis: View Previous Industry Report
